Podcast: what can European markets do with CBD Novel Food applications?

CBD as a food ingredient has essentially been on hold since European authorities declared cannabinoids to be “novel” – meaning they have not been consumed in the EU for long enough for safety to be guaranteed. The European Commission has also begun to wonder if they were a food item at all or if they would better fit under the definition of a narcotic as laid out in international treaties.

CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.

As well as the wide-ranging discussion of issues, he also discusses how – despite the current situation  – it might be an opportunity for the European sector and the market as a whole.

Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

    See more

    To further understand the impact and get the necessary background on Novel Food regulations and the industry, CBD-Intel recommends reading our exclusive report, which can be found here.

    If you need further details, feel free to contact us through this form or through any of our regular channels.

    Author default picture


    This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.